Several brokerages have updated their recommendations and price targets on shares of Novartis AG (NYSE: NVS) in the last few weeks:
Shares of Novartis AG (NYSE:NVS) traded down 0.36% during mid-day trading on Tuesday, reaching $74.83. 1,934,093 shares of the company traded hands. The company has a market capitalization of $177.65 billion, a P/E ratio of 26.73 and a beta of 0.73. The stock’s 50-day moving average is $75.57 and its 200-day moving average is $74.18. Novartis AG has a 52 week low of $66.93 and a 52 week high of $83.58.
Novartis AG (NYSE:NVS) last announced its earnings results on Wednesday, January 25th. The company reported $1.12 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $1.12. The company earned $12.32 billion during the quarter, compared to analysts’ expectations of $12.44 billion. Novartis AG had a net margin of 13.80% and a return on equity of 15.37%. The firm’s quarterly revenue was down 1.6% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.14 earnings per share. On average, equities analysts predict that Novartis AG will post $4.70 EPS for the current fiscal year.
The firm also recently announced an annual dividend, which was paid on Friday, March 3rd. Shareholders of record on Friday, March 3rd were given a dividend of $2.327 per share. The ex-dividend date of this dividend was Wednesday, March 1st. Novartis AG’s payout ratio is currently 82.14%.
Novartis AG is a holding company, which provides healthcare solutions. The Company is engaged in the research, development, manufacturing and marketing of a range of healthcare products led by pharmaceuticals. The Company’s segments include Innovative Medicines, Sandoz, Alcon and Corporate activities.